Theravance Biopharma, Inc. (NASDAQ:TBPH) Receives Consensus Recommendation of "Buy" from Analysts

Shares of Theravance Biopharma, Inc. (NASDAQ:TBPH - Get Free Report) have earned a consensus recommendation of "Buy" from the six brokerages that are covering the stock, MarketBeat Ratings reports. Two research analysts have rated the stock with a hold recommendation, two have assigned a buy recom